Callan Family Office’s MetLife MET Stock Holding History
Bought
Maintained
Sold
Other funds holding MET
Callan Family Office's MET Position: Q2 2026 in Review
Callan Family Office reduced its MetLife (MET) stake by 0.61% in Q2 2026, selling an estimated $64.7K and leaving 129,710 shares worth $11M. The position accounts for 0.21% of the portfolio, ranked #87.
Callan Family Office first reported a position in MET in Q1 2023 and has held it in 8 quarters since. The position peaked at $11.4M in Q2 2025. 1,442 funds tracked by Wall St. Rank hold MET as of Q2 2026.
- Callan Family Office held 129,710 shares of MetLife worth $11M as of Q2 2026.
- Callan Family Office sold 802 MetLife shares in Q2 2026, an estimated $64.7K.
- MetLife made up 0.21% of Callan Family Office's portfolio in Q2 2026, its #87 holding.
- Callan Family Office first reported a position in MetLife in Q1 2023 and has held it in 8 quarters since.
- Callan Family Office's MetLife position peaked at $11.4M in Q2 2025.
- 1,442 funds tracked by Wall St. Rank held MetLife as of Q2 2026.
Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.